New CCO strengthens global business strategy
Bristol-based cell and gene therapy CDMO eXmoor Pharma appointed Manuel Balbuena as Chief Commercial Officer at the beginning of March.
The new CCO Manuel Balbuena brings more than 15 years of experience to his new role at eXmoor Pharma. In recent years, he has held various senior positions in the life sciences sector, including seven years in the CDMO industry for cell and gene therapy and biologics. Balbuena joins from AGC Biologics, where he held senior sales roles across Europe.
As Chief Commercial Officer, he will lead eXmoor Pharma’s global business strategy, strengthen existing customer relationships, build new strategic partnerships and support the company’s expansion in Europe, the US and other international markets.
Lucy Foley, CEO of eXmoor Pharma, is delighted to have Balbuena on board: “Manuel joins eXmoor at an important stage in our development. His deep experience within the cell and gene therapy and biologics CDMO sector strengthens our ability to partner with global clients across a range of complex modalities. We are focused on building long-term strategic relationships and delivering commercial and operational excellence, and Manuel’s leadership will be central to that ambition.”
